MANASIBEN PATEL: Open Payments
NPI 1164177440 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 31 payments from 19 companies in 2025. Trend: 2023 $598 · 2024 $1,957 · 2025 $810
Food & beverage: $557Consulting: $230Education: $23
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $289 |
| Ipsen Biopharmaceuticals, Inc | 6 | $103 |
| ABBVIE INC. | 4 | $81 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $24 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
| Genmab U.S., Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $23 |
Products named: Trodelvy, Onivyde, IMBRUVICA, EPKINLY, Fabhalta, FRUZAQLA, Nubeqa, RYBREVANT.
Industry payments across NJ — which companies pay providers there.
